Vivendi saw its Q3 revenues increase by 0.7% yoy at constant currency and perimeter. A correct performance rather expected and primarily driven by the growth of UMG (+6.1% without, however, regaining the 12.7% of Q1).
An IPO of UMG is planned for 2022. This clearly means the stock could rise towards €30 in 2021 as the IPO approaches, if strong EBITA growth continues of course. One can already accumulate the stock at the current level.
21 Oct 2020
UMG not impervious to the crisis but still steadily growing
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
UMG not impervious to the crisis but still steadily growing
- Published:
21 Oct 2020 -
Author:
Jean-Michel Salvador -
Pages:
3
Vivendi saw its Q3 revenues increase by 0.7% yoy at constant currency and perimeter. A correct performance rather expected and primarily driven by the growth of UMG (+6.1% without, however, regaining the 12.7% of Q1).
An IPO of UMG is planned for 2022. This clearly means the stock could rise towards €30 in 2021 as the IPO approaches, if strong EBITA growth continues of course. One can already accumulate the stock at the current level.